UbiVac
Home Collaboration Investors Contact
New Index
Overview Executive Leadership Board of Directors Advisory Board
Technologies Pipeline
Presentations Publications Press Releases In the News
Home About Overview Executive Leadership Board of Directors Advisory Board Research & Pipeline Technologies Pipeline CollaborationInvestors Newsroom Presentations Publications Press Releases In the News Contact
UbiVac
New Index

Tumor-Derived Autophagosome Vaccine: Mechanism of Cross-Presentation and Therapeutic Efficacy

Yuhuan Li, Li-Xin Wang, Puiyi Pang, Zhihua Cui, Sandra Aung, Daniel Haley, Bernard A. Fox, Walter J. Urba, and Hong-Ming Hu

Clinical Cancer Research, November 15, 2011

Bernie FoxJune 4, 2018
Facebook0 Twitter 0 Likes
Previous

Autophagy-assisted Antigen Cross-presentation

Bernie FoxJune 4, 2018
Next

Tumor-Derived Autophagosome Vaccine: Induction of Cross-Protective Immune Responses Against Short-lived Proteins Through a p62-Dependent Mechanism

Bernie FoxJune 4, 2018

© 2020 UbiVac | All rights reserved.